Vor Biopharma Inc. (VOR)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

19.90 on 9 Oct 2026

0 buys30 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$695.98M

Free cash flow

$143.65M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
16 Jul 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Sold at will	$4.21K	0.0%
22 Apr 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sold at will	$2.60M	6.4%
20 Apr 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sold at will	$2.71M	6.3%
17 Apr 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sold at will	$7.46M	14.3%
15 Apr 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sold at will	$858.84K	1.6%
14 Apr 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sold at will	$2.46M	4.5%

3out of 100

Profitability 0

Financial strength 10

Growth n/a

Insiders 0

Strongest on financial strength (10), weakest on insiders (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$88.35M

30 sales

Planned sales

under a 10b5-1 plan